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IntroductIon
During viral infection, recognition of pathogen-associated 
molecular patterns activates transcription factors IFN regu-
latory factor 3/7 (IRF3/7) and NF-κB, leading to cytokine 
and IFN-α/β gene expression (Honda and Taniguchi, 2006; 
Brennan and Bowie, 2010). IFNs signal through the JAK/
STAT pathway and induce downstream expression of anti-
viral IFN-stimulated genes (ISGs). In addition to modulating 
the immune response, IFN-α/β is important for immune cell 
development (Li et al., 2011; Guan et al., 2014; Haynes et 
al., 2015). Dysregulation of IFN signaling can cause a wide 
range of disorders and chronic viral infections. Neutralization 
of type I IFN signaling during persistent lymphocytic chori-
omeningitis virus (LCMV) infection reduces immune system 
activation, restores lymphoid architecture, and allows for viral 
clearance (Teijaro et al., 2013; Wilson et al., 2013). Moreover, 
type I IFN receptor blockade prevents lethal vascular leakage 
in susceptible mice in an LCMV model of Lassa fever virus 
(Baccala et al., 2014). It is not clear how the immune system 
balances the beneficial and detrimental effects of IFN sig-
naling and how that affects viral infection outcomes. In our 
study, the role of IRF2, a type I IFN regulator, in alphavirus 
neuroinvasion and pathogenesis is investigated.
IRF2 is an ISG product that negatively regulates type 
I IFN production and signaling. IRF2 suppresses the ac-
tivity of IRF1, a positive regulator of IFN signaling, by 
competing for binding sites within the promoters of IFN 
genes and ISGs and potentially limiting the IFN response 
(Harada et al., 1989). Fibroblasts and peritoneal macrophages 
from IRF2 knockout (Irf2−/−) mice show increased type I 
IFN mRNA levels upon Newcastle disease virus infection 
(Matsuyama et al., 1993). Irf2−/− mice develop a CD8+ 
T cell–mediated inflammatory skin disease accompanied by 
ISG up-regulation (Hida et al., 2000; Taki, 2002). Knockout 
of genes that positively regulate IFN-α/β signaling, such as 
IFN AR1 that encodes one subunit of the IFN-α/β receptor 
or IRF9, abolishes disease development in Irf2−/− mice, indi-
cating a critical regulatory role for IRF2 in dampening IFN 
signaling (Hida et al., 2000; Taki, 2002). In addition, IRF2 
is important for the development and function of numerous 
immune cell types including DCs, NK cells, lymphocytes 
such as T and B cells, and hematopoietic stem cells (Mat-
suyama et al., 1993; Salkowski et al., 1996; Hida et al., 2000; 
Lohoff et al., 2000; Honda et al., 2004; Ichikawa et al., 2004; 
Taki et al., 2005; Sato et al., 2009; Minamino et al., 2012). 
However, no studies have investigated the maturation and 
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function of immune cell types in Irf2−/− mice during the 
course of a viral infection.
Studies done in the setting of IRF2 overexpression 
or deficiency demonstrate an antiviral role for this factor. 
IRF2 exhibits inhibitory effects against several viruses in 
ISG overexpression screens and synergizes with zinc fin-
ger antiviral protein, another ISG, to block Sindbis virus 
(SINV) replication (Schoggins et al., 2011, 2014; Karki et 
al., 2012). Irf2−/− mice succumb to acute infection with 
LCMV (Matsuyama et al., 1993). Despite vaccination with 
an attenuated strain 1 d earlier, Irf2−/− mice are suscepti-
ble to virulent Venezuelan equine encephalitis virus infec-
tion, suggesting IRF2 is required to mount a protective 
immune response (Grieder and Vogel, 1999). In humans, 
IRF2 variants are risk alleles for atopic dermatitis and 
eczema herpeticum, and some of these single-nucleotide 
polymorphisms are significantly associated with reduced 
IFN-γ production after stimulation with herpes simplex 
virus (Gao et al., 2012). Together, these data support a 
model in which IRF2 deficiency might lead to increased 
susceptibility to viral infection.
The Alphavirus genus (Togaviridae family) consists 
of arthropod-borne positive-sense RNA viruses that cause 
mild to severe disease in humans and animals. Alphavi-
ruses are found worldwide; the Old World viruses, such 
as SINV and chikungunya virus, cause fever, arthritis, and 
rash, whereas the New World viruses, such as Venezuelan 
equine encephalitis virus, can cause encephalitis. SINV, the 
well-characterized prototype alphavirus, provides a facile 
model system for studying encephalitis in vivo. Patho-
genesis of SINV greatly depends on the virus strain used, 
route of infection, and the age and genetic background of 
the mice (Lustig et al., 1988; Sherman and Griffin, 1990; 
Klimstra et al., 1999; Ryman et al., 2000, 2007; Ryman 
and Klimstra, 2008). Different SINV strains exhibit dif-
ferent abilities to infect the central nervous system (CNS) 
and cause disease. Some SINV strains are both neurovir-
ulent (replicate in the brain to cause disease) and neuro-
invasive (can invade the CNS and cause disease even after 
peripheral inoculation), whereas others are neurovirulent 
but noninvasive and cause encephalitis only when directly 
inoculated into the brain.
Although mechanisms underlying SINV pathogen-
esis have been extensively studied, the role of host factors, 
which modulate viral neuroinvasion after peripheral inocula-
tion in mice with an intact blood–brain barrier (BBB) and a 
mature immune system, has not been fully explored. Here, 
we found that IRF2 deficiency confers lethal neuroinva-
sion on a normally noninvasive SINV strain. We performed 
detailed virological, histological, and immunological studies 
to fully characterize the host response to SINV. Our data sug-
gest that defects in multiple immune cell types likely contrib-
ute to altered B cell trafficking and pathogenic phenotype in 
the Irf2−/− mice and highlight the important role of IRF2 in 
the development of the immune system.
reSultS
IrF2 protects mice from lethal viral neuroinvasion
To study IRF2’s antiviral effects on SINV replication in vivo, 
Irf2−/− and WT mice were challenged i.p. with SVN, a neu-
rovirulent but noninvasive strain, which normally replicates 
only in the periphery without lethality in mice (Lustig et al., 
1992). Clinical score, weight loss, and survival of the animals 
were monitored daily as previously described (Gardner et al., 
2008). Approximately 70% of the Irf2−/− mice succumbed to 
infection with SVN, whereas all of the WT littermate con-
trol mice survived (Fig. 1 A), indicating that IRF2 deficiency 
confers lethal neuroinvasive properties on the normally non-
invasive SVN strain. Although early disease symptoms were 
similar in the WT and Irf2−/− mice, the disease rapidly pro-
gressed in the Irf2−/− animals (Fig. 1 B). At early times (days 1 
and 2) after i.p. infection, low virus titers were detected in the 
brains of similar numbers of WT and Irf2−/− mice (Fig. 1 C). 
However, on day 3, virus was not detected in any of the WT 
mice yet was detected in the brains of all the Irf2−/− mice. 
At later times, the majority of Irf2−/− mice had high brain 
viral titers up to 108 PFU/g, whereas an occasional WT an-
imal also had significant viral replication in the brain. These 
results clearly suggested a failure to clear virus in the brains 
of the Irf2−/− mice. When virus replication in the periphery 
was monitored, both WT and Irf2−/− mice had similar titers 
in the serum, which was cleared with similar kinetics, but the 
Irf2−/− mice demonstrated prolonged virus replication in the 
liver and spleen (Fig. 1 C). The difference in viral replication 
in the brain and the effect of IRF2 on the infection outcome 
were not caused by a difference in the ability of the virus to 
replicate in neuronal tissue, as direct inoculation of SVN into 
the brains was uniformly lethal for both WT and Irf2−/− mice 
(Fig. 1 D). To determine whether IRF2 also protects mice 
from other neurotropic viruses, Irf2−/− and WT littermate 
control mice were challenged by i.p. injection with vesicular 
stomatitis virus (VSV). VSV is known to replicate efficiently 
in the brain and spinal cord and cause acute encephalitis and 
death in mice by intranasal injection but is highly attenuated 
and results in no apparent disease after i.p. inoculation (Hastie 
et al., 2013). Infection with VSV led to survival of all the 
WT mice, whereas ∼60% of the Irf2−/− mice suffered from 
paralysis and succumbed to infection (Fig.  1  E). Together, 
these data suggest that IRF2 prevents lethal neuroinvasion 
of a variety of disparate neurotropic viruses that normally 
would not efficiently replicate in the CNS after infection 
through a peripheral route.
Massive neuronal death in Irf2−/− mouse brains  
is not accompanied by immune infiltration
Because the hind limb weakness observed in the WT 
mice never developed into full-blown paralysis and death 
(Fig.  1  B), we were interested in identifying differences in 
the virus-induced CNS damage and the host inflammatory 
response in SVN-infected WT and Irf2−/− animals. We did 
not detect any sign of pathological changes in the brains of 
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the WT and Irf2−/− mice on day 1 postinfection (p.i.) when 
their viral titers were similar. Therefore, we performed histo-
logical characterization of various organs of infected WT lit-
termate controls and moribund Irf2−/− mice on days 6–7 p.i. 
WT mouse brains did not exhibit any evidence of pathologi-
cal changes when stained with hematoxylin and eosin (H&E; 
Fig. 2 A, left). In contrast, neurons were shrunken, angular, 
and hypereosinophilic (consistent with neuronal cell death), 
and the neuropil was vacuolated in both the hippocampus 
and diencephalon of the Irf2−/− mice (Fig. 2 A, middle). The 
extensive neuronal death was consistent with the known tro-
pism of SINV to replicate mainly in the neurons of the CNS 
(Jackson et al., 1987, 1988; Sherman and Griffin, 1990). Next, 
we looked for accumulation of lymphocytes and plasma cells 
around blood vessels, which was minimal in the brains of both 
SVN-infected WT and moribund Irf2−/− mice (Fig. 2 B, left 
and middle). Terminal deoxynucleotidyl transferase deoxyu-
ridine triphosphate nick-end labeling (TUN EL) stain, which 
detects DNA fragmentation in both apoptotic and necrotic 
cells, was undetectable in WT mouse brains, whereas foci of 
staining, mostly in the hippocampus, were characteristic of 
moribund Irf2−/− mouse brains (Fig. 2 C, left and middle). In 
addition, mild myocardial calcification was evident in some 
Irf2−/− mice but was never observed in WT mice. Cytoplas-
mic viral capsid staining of heart muscle cells was observed 
in one of these Irf2−/− animals, suggesting the heart lesions 
might be caused by viral replication. Our finding was consis-
tent with previous studies that identified virus replication and 
associated tissue damage in the hearts of SINV-infected neo-
natal mice (Trgovcich et al., 1996; Klimstra et al., 1999). The 
Figure 1. IrF2 prevents lethal neuroinvasion of disparate neurotropic viruses. (A and B) Mortality (A) and disease progression (B) of mice infected i.p. 
with 13,000 PFU SVN were monitored for 14 d. For mortality, a total of 14–15 mice per genotype were infected, divided among seven independent experi-
ments. For measuring clinical symptoms, 9–10 mice per genotype were scored each day. The p-value for the survival curve was determined by the log-rank 
test (P < 0.0001). (C) Viral titers in various tissues of mice infected i.p. with SVN were measured on days 0–7 p.i. Brain, serum, liver, and whole spleens from 
three to six mice per genotype per time point were harvested and/or homogenized for infection of BHK-21 cells in plaque assays. The dashed line indicates 
the plaque assay detection limit. Lines represent the mean. Two-way ANO VA test: brain, P < 0.0001; whole spleen, P < 0.001. Bonferroni posttests: *, P < 
0.05; **, P < 0.01; ***, P < 0.001. (D) Mortality of mice infected intracranially (I.C.) with 13,000 PFU SVN was monitored for 7 d. A total of 7–10 mice per 
genotype were infected, divided among four independent experiments. The p-value for the survival curve was determined by the log-rank test. (E) Mortality 
of mice infected i.p. with 10,000 PFU VSV was monitored for 14 d. A total of seven mice per genotype were infected in four independent experiments. The 
p-value for the survival curve was determined by the log-rank test (P = 0.02).
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histological findings demonstrate extensive neuronal death 
and tissue damage unaccompanied by immune infiltration in 
SVN-infected Irf2−/− mice. However, the WT mice lack signs 
of CNS destruction and encephalitis, with no noticeable in-
flammatory infiltrate, which is likely caused by the absence of 
viral replication in the brains of these animals late in infection.
Despite a rare event, high brain viral titers were detected 
in two WT mice on days 4–5 p.i. (Fig. 1 C), allowing us to ask 
whether there were differential host responses in Irf2−/− ver-
sus WT animals in the presence of similar levels of viral repli-
cation in the CNS. SVN-infected WT mice were euthanized, 
and their brains were harvested. Five WT mice were identified 
to have a substantial viral RNA copy number (8.4 × 103 to 2 
× 107 copies/µg total brain RNA), and the brains from these 
mice were processed for histological examination. There was 
minimal neuronal shrinkage and death in the brains of these 
WT animals with positive brain viral titers (Fig. 2 A, right). 
However, compared with Irf2−/− animals, significantly more 
immune cell infiltration was observed on day 5 p.i., char-
acterized by a perivascular cuffing pattern (Fig. 2 B, right). 
Perivascular cuffing is indicative of an inflammatory response 
associated with a favorable disease outcome in a previous 
study that investigated the age-dependent susceptibility of 
mice to fatal SINV infection (Trgovcich et al., 1999). Only a 
few isolated cells were marked by the TUN EL stain (Fig. 2 C, 
right). Quantification of viral capsid staining of whole-brain 
sections confirmed that these WT mice had viral replication 
in their brains that was not significantly lower than that in the 
brains of moribund Irf2−/− mice (Fig. 2 D). Altogether, these 
data show that Irf2−/− animals are unable to mount a protec-
tive inflammatory response including recruitment of immune 
cells, which correlates with massive neuronal death and CNS 
damage not seen in the WT mice with positive brain titers.
Blockade of type I IFn signaling fails to rescue Irf2−/− mice
Given IRF2’s known role in negatively regulating type 
I IFN signaling, we measured IFN-α in the serum of WT 
and Irf2−/− mice after i.p. infection with SVN. In WT mice, 
IFN-α production peaked on day 1 p.i. and waned to un-
detectable levels by day 3 p.i.; however, in Irf2−/− mice, the 
IFN-α level persisted during the course of the infection and 
was significantly higher than that in WT animals on days 3 
and 6 p.i. (Fig. 3 A). Next, we asked whether this persistent 
IFN signaling in Irf2−/− mice led to up-regulation of inflam-
matory cytokines. Although the level of monocyte chemo-
tactic protein 1 (MCP-1) was mostly undetectable (5–40 pg/
ml serum) and that of IL-6 was comparable (200–900 pg/
ml serum) in the serum of WT and Irf2−/− mice, they were 
Figure 2. extensive neuronal death is observed only in the brains of Irf2−/− mice but not in those of Wt mice with high viral titers. (A–C) Rep-
resentative brain images of three SVN-infected mice from three different groups that demonstrate differences in neuronal morphology (A), perivascular 
cuffing (B), and neuronal cell death by TUN EL staining (C) are shown. Sections of brain from five SVN-infected WT littermate control mice (left; one animal), 
five moribund Irf2−/− mice (middle; one animal), and six WT mice with high CNS viral titers (right; one animal) were stained with H&E and examined for 
neuronal cell death (arrows), neuropil vacuolation (asterisks; A), and perivascular cuffing (arrowheads) by morphology (B). (C) TUN EL staining of slides fur-
ther confirmed the presence of dead cells (brown; arrows). Bars: (A and C) 50 µm; (B) 100 µm. (D) SINV capsid staining of brain slides from the same mice 
including those with high CNS viral titers was quantified by ImageJ. A sagittal section of the entire brain near the midline was used for viral antigen staining. 
The p-value was determined by the unpaired, two-tailed Student’s t test. pos, positive.
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significantly up-regulated in Irf2−/− mouse brains by day 5 
p.i. (Fig. 3 B). We hypothesized that IRF2 deficiency might 
lead to production of cytokines that damaged the BBB, re-
sulting in uncontrolled viral replication. To measure the BBB 
integrity, we injected Evans blue, a dye that is normally ex-
cluded from the CNS, into the SVN-infected WT and Irf2−/− 
mice by i.p. route on day 2 (when low levels of virus were 
detectable in the mouse brains of both genotypes), day 3 
(when the virus was cleared in WT mouse brains but repli-
cating to high levels in Irf2−/− mouse brains), and day 5 (a day 
before when Irf2−/− mice started dying) p.i. On days 2 and 3 
p.i., Evans blue entry into the brains of WT and Irf2−/− mice, 
as assessed by fluorescence intensity of brain homogenates, 
was comparable with that of uninfected mice (Fig. 3 C). By 
day 5 p.i., accumulation of dye was detected in some of the 
Irf2−/− animals, although the mean fluorescence intensities of 
WT and Irf2−/− mouse brains were not significantly differ-
ent. The data show that BBB permeability changes are likely 
not the cause for uncontrolled viral replication but, rather, a 
result of the massive viral replication and disease in Irf2−/− 
brains during infection.
Next, we measured the mRNA levels of representative 
ISGs with different roles in IFN signaling. IFI TM3, BST2, 
IFIT1, and MX1 encode antiviral effectors whereas OAS1B, 
protein kinase R (PKR), and IRF1 gene products are positive 
regulators of IFN signaling (Schneider et al., 2014). We found 
higher expression of all the ISGs tested in the brains of Irf2−/− 
mice on days 3 and 5 p.i. (Fig. 3 D). However, WT mice with 
high brain viral titers (the same mice studied in Fig.  2 D) 
also expressed enhanced levels of these ISGs on day 5 p.i. 
(Fig. 3 D), suggesting that expression of ISGs in the brain is 
induced by SVN replication and not specific to the Irf2 gen-
otype of the mice. We hypothesized that peripheral elevated 
type I IFN signaling in Irf2−/− animals might contribute to 
accelerated disease in the CNS. To address this, we injected 
Irf2−/− mice i.p. with IFN AR1-neutralizing antibody before 
or after infection with SVN to determine whether block-
ade of type I IFN signaling could rescue Irf2−/− mice from 
lethal neuroinvasion. The WT mice were also treated with 
IFN AR1-neutralizing antibody before or after infection 
with SVN as a control. We found that the survival of the 
Irf2−/− mice treated with IFN AR1-blocking antibody 1 d be-
fore SVN infection was significantly compromised (Fig. 3 E, 
left), which, similar to a previous study (Ryman et al., 2000), 
showed that IFN signaling plays a protective role upon viral 
challenge. However, the survival of Irf2−/− mice treated with 
IFN AR1-blocking antibody 2 d p.i. was very similar to that 
of Irf2−/− mice treated with an isotype control antibody, sug-
gesting that the protective effects of IFN likely take place 
early during infection (Fig.  3  E, left). Consistent with the 
findings of the Irf2−/− animals, the survival of the WT mice 
treated with various amounts of IFN AR1-blocking antibody 
was compromised, although up to 1 mg was required to sig-
nificantly decrease the survival of the WT animals (Fig. 3 E, 
right). Our results suggest that peripheral elevated type I IFN 
signaling during infection is not responsible for the increased 
pathology associated with IRF2 deficiency, as neutralization 
of IFN results in even more severe disease. Given the known 
role of IRF2 in negative regulation of type I IFN at base-
line, we investigated the possibility that dysregulation of the 
IFN response during the development of the immune system 
might account for the Irf2−/− phenotype.
IrF2 is indispensable for the development and functional 
maturation of multiple immune cell types at baseline 
and upon viral challenge
To investigate the importance of IRF2 in the development 
and maturation of the immune system, we conducted a phe-
notypic assessment of the major cell types present in the 
mouse spleen at baseline and during SVN infection on days 
1–2 and 5 d p.i., which allowed us to characterize the im-
mune response in the periphery before viral clearance in WT 
mouse brains and before when Irf2−/− mice started dying, 
respectively. Bulk splenocytes from uninfected and SVN- 
infected WT and Irf2−/− mice were stained for flow cytomet-
ric analyses with antibodies specific for T cell, B cell, gran-
ulocyte, macrophage, DC, monocyte, and NK cell surface 
markers (see Fig. S1 for gating strategy). The frequency of 
splenic NK cells was significantly lower in Irf2−/− mice than 
that in WT mice at baseline (Fig. 4 A). Depending on the 
time of analysis, lower percentages of B cells, monocytes, and 
NK cells were present but a higher percentage of granulo-
cytes was detected in Irf2−/− mice after infection (Fig. 4 A). 
Further analyses of specific immune cell subsets revealed that 
the proportions of CD4+ and CD8+ T cells were significantly 
different (more CD4+ and less CD8+ T cells) in Irf2−/− mice 
compared with WT mice on days 1 and 5 p.i. (Fig. 4 B). The 
frequencies of CD8+ and CD11b+ classical DCs (cDCs) were 
significantly altered at baseline and on days 1, 2, and 5 p.i. 
in Irf2−/− mice (Fig. 4 C). In addition, NK cells in different 
developmental stages as described in a previous study (Chi-
ossone et al., 2009) were identified and quantified. During 
infection, percentages of the immature CD11bloCD27lo and 
CD11bloCD27hi NK subsets progressively dropped in the WT 
mice, likely to give rise to the more mature CD11bhiCD27hi 
and CD11bhiCD27lo subsets, which steadily increased 
(Fig. 4 D). On the contrary, the more mature CD11bhiCD27hi 
and CD11bhiCD27lo NK cells were significantly decreased in 
Irf2−/− mouse spleens, whereas the immature CD11bloCD27lo 
and CD11bloCD27hi cells were more pronounced (Fig. 4 D). 
Significant differences were observed in the frequencies of 
the following NK subsets between WT and Irf2−/− mice: 
CD11bhiCD27lo on day 1 p.i. (P < 0.001), at baseline, and 
on days 2 and 5 p.i. (P < 0.0001); CD11bhiCD27hi at baseline 
(P < 0.01), on days 1 and 5 p.i. (P < 0.001), and on day 2 
p.i. (P < 0.0001); CD11bloCD27hi on days 1, 2, and 5 p.i. (P 
< 0.0001); and CD11bloCD27lo at baseline and on days 2 
and 5 p.i. (P < 0.0001). Moreover, we investigated two sub-
sets of the CD115+ CD11b+ monocyte population: Ly6Clo 
patrolling monocytes and Ly6Chi proinflammatory mono-
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Figure 3. dysregulation of type I IFn signaling during SVn infection is not the cause of accelerated disease and death in Irf2−/− mice. (A) Serum 
IFN-α levels in WT and Irf2−/− mice on days 0–7 p.i. were measured by ELI SA during SVN infection. Between three and six infected mice per genotype per 
time point were tested. Because 70% of the Irf2−/− mice succumbed to SVN infection between days 6 and 8 p.i., serum samples from less than three mice 
were tested on days 6 and 7 p.i. The dotted line indicates the detection limit of the ELI SA (concentration of the lowest standard), and error bars represent 
SD. P-values were determined by the unpaired, two-tailed Student’s t test. *, P = 0.0167; **, P = 0.0073. (B) Protein concentrations of MCP-1 and IL-6 were 
measured by cytometric bead array. The right halves of the brains from three to four mice per genotype at baseline or on days 1, 3, and 5 p.i. were harvested 
and homogenized for measurement of inflammatory cytokines. Error bars represent SD. Two-way ANO VA test: MCP-1, P < 0.0001; IL-6, P < 0.05. Bonferroni 
posttests: ****, P < 0.0001. (C) Mice were infected i.p. with SVN and injected i.p. with Evans blue (EB) dye to measure BBB permeability on day 2, 3, or 5 p.i. 
Evans blue cannot cross the BBB unless there is a breach. Brains were harvested and homogenized 3 h after dye injection, and fluorescence present in the 
homogenates was measured spectrophotometrically. Between five and six mice per genotype served as uninfected controls or were infected, injected with 
the dye at various time points p.i., and harvested in a total of 11 independent experiments. Between two and four SVN-infected mice per genotype were 
not injected with the dye but instead harvested for measurement of background fluorescence. RU, relative units. (D) mRNA levels of the indicated ISGs in 
the brains of WT and Irf2−/− mice were measured by RT-qPCR. The right halves of the brains from three to four mice per genotype at baseline or on days 
1, 3, and 5 p.i. were harvested and homogenized for RNA extraction. ISG mRNA levels present in the brains of the five WT mice with high CNS viral titers 
(Fig. 2 D) were also determined. Fold-changes normalized to baseline WT mice for all ISGs tested are shown in the table. ISG mRNA fold-changes with 
significant differences between the WT and Irf2−/− mice were determined using a two-way ANO VA test (IFI TM3, P < 0.05; IFIT1, P < 0.05) and Bonferroni 
posttests (IFI TM3 on day 5 p.i., P < 0.01; IFIT1 on day 5 p.i., P < 0.01; MX1 on day 5 p.i., P < 0.05; protein kinase R [PKR] on day 5 p.i., P < 0.01; IRF1 on day 
5 p.i., P < 0.05). pos, positive. (E) Mortality of mice treated with 500 µg or 1 mg IFN AR1-blocking antibody or 500 µg isotype control antibody by i.p. route 
1 d before or 2 d after i.p. infection with SVN. A total of 9–11 Irf2−/− and 7–10 WT mice were treated with IFN AR1-blocking antibody or isotype control and 
infected with SVN, divided among nine independent experiments. The p-values for survival curves were determined by the log-rank test. Only the significant 
differences are shown (isotype vs. IFN AR1 500 µg day −1 Irf2−/−, P = 0.0044; isotype vs. IFN AR1 500 µg 2 d p.i. Irf2−/−, P = 0.0436; isotype vs. IFN AR1 1 mg 
day −1 Irf2+/+, P = 0.0479).
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cytes (Hanna et al., 2011; Shi and Pamer, 2011). We found 
dramatically lower percentages of Ly6Clo monocytes in 
Irf2−/− mice at baseline and on days 1 and 2 after SVN infec-
tion, whereas Ly6Chi monocytes existed at a higher frequency 
on day 1 p.i. (Fig.  4 E). Our findings clearly highlight the 
function of IRF2 in maintaining the homeostasis of different 
immune cell lineages in the spleen.
Because IRF2 deficiency dramatically compromised 
the frequency and maturation of multiple immune cell 
types, we took depletion and reconstitution approaches to 
investigate whether one or several of these affected cell 
types contributed to lethal SVN neuroinvasion. We fo-
cused on NK cells, cDCs, and monocytes because they 
were most significantly altered by IRF2 knockout and/or 
important for SINV infection (Ryman and Klimstra, 2008). 
First, we depleted the NK cells in the WT mice 1 d before 
viral infection to probe the protective role of NK cells in 
SVN pathogenesis. Although our depletion conditions led 
Figure 4. development and maturation of 
multiple immune cell subsets are compro-
mised in Irf2−/− mice at baseline and upon 
SVn infection. (A) Bulk splenocytes from un-
infected and SVN-infected WT and Irf2−/− mice 
on days 1, 2, and 5 p.i. were isolated and 
stained with antibodies specific for T cell (T), 
B cell (B), granulocyte (Gran), macrophage 
(Mac), DC, monocyte (Mono), and NK cell 
surface markers for flow cytometric anal-
yses (see Fig. S1 for gating strategy). The 
graphs show frequencies of various immune 
cell populations as percentages of live sple-
nocytes (black bars, WT; red bars, Irf2−/−). 
(B–E) The percentages of CD4+ and CD8+ T cells 
(B), CD8+ and CD11b+ cDCs (C), NK subsets 
with increasing maturation indicated by color 
intensity (D), and Ly6Chi and Ly6Clo monocytes 
(E) are shown. Black open triangles and red 
closed circles represent WT and Irf2−/− mice, 
respectively. Spleens from two to seven mice 
per genotype per time point were analyzed in a 
total of seven independent experiments. Error 
bars represent SD. Bonferroni posttests: *, P < 
0.05; **, P < 0.01; ****, P < 0.0001.
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to a 95% reduction in the frequency of CD3− NK1.1+ 
cells, there was no significant difference in the survival of 
the WT mice lacking splenic NK cells (Fig.  5  A). Our 
finding was consistent with a previous study that showed 
no role for NK cells in protection from SINV (Hirsch, 
1981). Mononuclear phagocytes (MNPs) consist of mac-
rophages, monocytes, and DCs and can be depleted with 
clodronate liposomes. We asked whether removing MNPs, 
including cDCs and monocytes that were negatively im-
pacted by IRF2 deficiency, affects SINV pathogenesis. If 
Irf2+/+ MNPs are protective, depletion would cause ac-
celerated disease in WT mice. However, if the Irf2-null 
MNPs are detrimental, depletion would ameliorate disease 
in Irf2−/− mice. We treated WT and Irf2−/− mice with clo-
dronate to deplete MNPs or used PBS liposomes as a con-
trol and found no significant difference in the survival of 
the mice under these two conditions (Fig. 5 B). However, 
there was large variability among animals in cDC, macro-
phage, and monocyte depletion by clodronate liposomes. 
We observed that 93–96% of macrophages (three out of 
four mice), 36–56% of cDCs (three out of four mice), and 
46–58% of Ly6Clo patrolling monocytes (four out of four 
mice) were depleted, whereas Ly6Chi proinflammatory 
monocytes were unaffected (four out of four mice). Given 
the age and size of the animals, we were unable to use 
tail vein administration, which is known to be more effi-
cient at phagocytic depletion. All in all, these data suggest 
that none of the cell types that were removed from WT or 
Irf2−/− mice are sufficient to reverse the phenotype. IRF2 
likely creates a supportive environment for the prolifera-
tion and maturation of multiple immune cell subsets that 
together protect mice from lethal neuroinvasion.
B cell number and virus-specific IgG level are significantly 
lower in Irf2−/− mouse brains
A major difference in the host response to SVN infection 
between moribund Irf2−/− mice and the few littermate 
control WT mice with high viral brain titers was immune 
infiltration (Fig.  2  B, middle and right). We next asked 
whether higher numbers of one or multiple immune cell 
types were observed in WT mouse brains. Adjacent sections 
from the brains of SVN-infected Irf2−/− and WT mice with 
high CNS viral titers (Fig.  2 D) were stained with anti-
bodies specific for T cells, B cells, granzyme-containing 
cells (cytotoxic CD8+ T and NK cells), and macrophages. 
Each was examined and scored semiquantitatively for the 
frequency of positively stained cells. The brains of WT mice 
had a higher number of B cells compared with those of the 
Irf2−/− mice, whereas the other cell types existed at similar 
frequencies among the mice (Fig. 6 A). Images that con-
sistently sampled eight different regions in the brains (Fig. 
S2) of WT and Irf2−/− mice were used to quantify B cell 
staining by ImageJ or by manual cell counting. Consistent 
with the semiquantitative histological scoring (Fig. 6 A), 
the WT mice with positive viral titers in the brains had a 
significantly higher number of B cells compared with the 
moribund Irf2−/− mice (Fig. 6 B). To understand whether 
the elevated B cell numbers in WT mouse brains correlate 
with an effective immune response, we measured the levels 
(Fig. 6 C) and quality (Fig. 6 D) of SVN-specific antibodies 
in the serum and brains of WT and Irf2−/− mice infected 
with SVN. Interestingly, although both WT and Irf2−/− 
mice were able to mount virus-specific antibody responses 
in the periphery that can effectively neutralize SVN (Fig. 6, 
C and D), only WT mice had a robust SINV-specific IgG 
titer in the brain, which occurred on day 7 p.i. (Fig. 6 C). 
These antibodies could either enter the brain through a 
breach in the BBB or be produced locally by B cells that 
have infiltrated the CNS. The latter was more likely because 
the levels of virus-specific IgG in the periphery were com-
parable between WT and Irf2−/− animals before day 7 p.i. 
B cell migration to or proliferation in the Irf2−/− mouse 
brains was likely deterred, leading to lower numbers of B 
cells and lower levels of virus-specific IgG in the CNS. Our 
findings suggest that B cell number in the mouse brains is 
affected by IRF2 deficiency, which is consistent with the 
immune defects observed in the periphery.
Figure 5. depletion of nK cells or MnPs does not significantly alter 
viral pathogenesis. (A) Mortality of WT mice treated i.p. with 300 µg 
NK1.1 antibody (Ab) or an isotype control 1 d before i.p. infection with SVN 
was monitored. A total of six to seven WT mice were treated and infected, 
divided between two independent experiments. (B) Mortality of WT and 
Irf2−/− mice treated i.p. with 200 µl clodronate or PBS liposomes 3 d before 
i.p. infection with SVN was monitored. A total of 9–12 mice per genotype 
were treated and infected, divided among eight independent experiments. 
The p-values for survival curves were determined by the log-rank test.
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Proper localization of B cells and antibodies to the cnS  
is required for protection
To demonstrate that B cells are critical for protection from 
SVN infection, B cell–deficient μMT mice and age-matched 
WT C57BL/6J mice were challenged with SVN (Fig. 7 A). 
We found that μMT mice were significantly more suscepti-
ble to SVN-induced paralysis and death, suggesting that B 
cells are required for protection from lethal neuroinvasion. To 
test the hypothesis that B cells and a virus-specific antibody 
response are required in the CNS, we adoptively transferred 
WT B cells and serum to Irf2−/− mice. B cells were isolated 
from naive WT mice and retroorbitally adoptively transferred 
to Irf2−/− mice (and WT controls) 1 d before infection with 
SVN (Fig.  7 B). Whereas only one out of eight WT mice 
succumbed to SVN infection, six out of six Irf2−/− mice died 
by day 9 p.i., suggesting that B cells from naive WT mice 
are not sufficient to rescue Irf2−/− mice from the disease. In 
addition, serum was harvested from SVN-infected mice on 
day 7 p.i. and i.p. adoptively transferred to Irf2−/− mice (and 
WT controls) 1 d after infection (Fig. 7 C). Day 7 p.i. was 
chosen because it was the day when a significant difference 
in the levels of virus-specific IgG was observed in the brains 
Figure 6. B cells and virus-specific IgG level are significantly reduced in Irf2−/− mouse brains. (A) Brain slides from five Irf2−/− moribund mice and 
six SVN-infected WT mice with high CNS viral titers from Fig. 2 D were stained with antibodies specific for CD3 (T cell), B220 (B cell), granzyme (cytotoxic 
T and NK cells), and Mac2 (macrophage). Immune cell infiltrates were semiquantitatively scored using a scale of zero to four as follows: 0, absent; 1, min-
imal; 2, mild; 3, moderate; and 4, marked. (B) Images that consistently sample eight different regions in the brains (Fig. S2) of WT and Irf2−/− mice were 
taken, and the B cell staining present in those images was quantified by ImageJ (measurement of number of positive pixels) or by eye (number of B cells). 
The p-values were determined by the unpaired, two-tailed Student’s t test (*, P < 0.05). pos, positive. (C) SINV-specific IgG and IgM antibodies in serum and 
brain homogenate samples of infected mice were measured by ELI SA, as detailed in the ELI SA section of Materials and methods. Mean OD value represents 
the level of virus-specific IgG or IgM antibody. Serum samples from three to six mice (except for n = 2 for Irf2−/− on day 7 p.i.) and brain homogenates from 
three mice per genotype per time point were tested for antibody titers. Error bars represent SD. Bonferroni posttests: *, P < 0.05. (D) PRNT was performed 
on serum samples of uninfected (n = 1 per genotype) and day 5 SVN-challenged WT and Irf2−/− mice (n = 4–5 per genotype). Infection with a constant 
concentration of virus incubated with serum samples from uninfected mice resulted in ∼200 plaques per well. The point at which the dilution curve crosses 
the dotted line represents the concentration of serum from SVN-infected mice required to reduce the number of plaques by 50%.
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but not in the periphery of WT and Irf2−/− mice. We found 
that serum transfer did not protect all Irf2−/− mice from le-
thal neuroinvasion by SVN, although a higher percentage of 
Irf2−/− mice survived compared with those that received no 
serum (Fig. 1 A). Because we administered the serum to the 
mice much earlier (1 d p.i.) than when they actually would 
mount an antibody response (Fig. 6 C), it is possible that the 
slight protective effect was caused by virus neutralization in 
the periphery before virus gaining access to the brain. How-
ever, overall, our data suggest that antibodies in the periphery 
fail to adequately protect mice from fatal CNS disease, likely 
because of the inability of the antibodies to cross the BBB. 
Collectively, our data suggest that appropriate environmental 
cues missing in Irf2−/− mice are required for B cell trafficking 
and function, and protection in WT mice is likely conferred 
by proper localization of B cells and antibodies to the CNS.
dIScuSSIon
We reported in this study that IRF2 deficiency confers rapid 
and lethal neuroinvasion of SVN that is typically cleared from 
the brains of WT mice. A mosquito isolate of SINV, the SV 
strain, was serially passaged in suckling and weanling mouse 
brains to generate SVN (neurovirulent but noninvasive) and 
SVNI (neurovirulent and invasive; Lustig et al., 1992). Both 
SVN and SVNI can cause lethal encephalitis after intracra-
nial inoculation, but only SVNI can invade the CNS and 
cause high levels of replication in the brain upon peripheral 
infection (Lustig et al., 1992). Intriguingly, the lack of IRF2 
converts the phenotype of SVN to that of SVNI. It is possible 
that IRF2 normally prevents SVN from efficiently entering 
the CNS by mechanisms similar to those used by SVNI. The 
determinants for neuroinvasion of SVNI are mapped to three 
mutations, two of which confer amino acid changes in the E2 
glycoprotein, which is important for cellular entry (Dubuisson 
et al., 1997). A study using packaged SINV replicons demon-
strated that mutations in E2 confer the ability to infect human 
DCs, suggesting that infection of innate immune subsets such 
as DCs might be critical for SINV neuroinvasion (Gardner 
et al., 2000). IRF2 deficiency might facilitate more efficient 
infection of immune cells by SVN, and as a result, the virus 
spreads to the CNS and causes lethal neuroinvasion in mice.
In addition, our study points to a relationship between 
IRF2 expression and immune cell development. Frequencies 
of both total and subset populations of multiple cell types are 
altered in the spleens of Irf2−/− mice. Irf2−/− mice have not only 
fewer NK cells and proportionally less mature cells at baseline, 
but also reduced expansion of the more mature NK subsets 
during infection compared with WT animals (Fig. 4, A and 
D). Because CD11bhiCD27hi and CD11bhiCD27lo NK cells 
differentiate from CD11bloCD27lo and/or CD11bloCD27hi 
cells and a major difference between CD11bloCD27hi and 
CD11bhiCD27lo NK cells is their proliferative potential (Chi-
ossone et al., 2009), it is likely that immature NK cells are 
defective in proliferation and differentiation into the more 
mature subsets in Irf2−/− mice at baseline and upon viral chal-
lenge. IRF2 can affect NK cell development either directly or 
indirectly by altering the development of other immune cell 
types required for the development of NK cells. DCs, which 
were also affected by IRF2 deficiency, have been shown to 
control NK cell proliferation and effector functions (Lucas et 
al., 2007; Hochweller et al., 2008). In our study, the frequency 
of Ly6Clo monocytes was dramatically affected by IRF2 de-
ficiency. At baseline and after infection, Irf2−/− mice have a 
lower frequency of Ly6Clo patrolling monocytes but a higher 
frequency of Ly6Chi inflammatory monocytes compared 
Figure 7. B cells are protective against lethal viral neuroinvasion. 
(A) Mortality of B cell–deficient μMT and age-matched WT C57BL/6J mice 
infected i.p. with 13,000 PFU SVN was monitored for 18 d. A total of 9–16 
mice per genotype were infected, divided between two independent ex-
periments. The p-value for the survival curve was determined by the log-
rank test (P = 0.0182). (B) WT and Irf2−/− mice with B cells retroorbitally 
adoptively transferred from WT mice were infected i.p. with 13,000 PFU 
SVN the day after, and their mortality was monitored for 14 d. A total of 
six to eight mice per genotype were infected, divided between two inde-
pendent experiments. The p-value for the survival curve was determined by 
the log-rank test (P = 0.001). (C) WT and Irf2−/− mice were infected i.p. with 
13,000 PFU SVN, and 1 d later, serum from infected WT mice (day 7 p.i.) 
was adoptively transferred to the animals. Their mortality was monitored 
for 14 d. A total of 10 mice per genotype were infected, divided among five 
independent experiments. The p-value for the survival curve was deter-
mined by the log-rank test.
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with WT mice (Fig. 4 E). Our data suggest that differentia-
tion of Ly6Clo monocytes from Ly6Chi ones might be defec-
tive in the absence of IRF2, although it is still controversial 
whether Ly6Clo monocytes differentiate directly from a bone 
marrow progenitor or from mature Ly6Chi monocytes (Varol 
et al., 2007; Auffray et al., 2009; Hanna et al., 2011). Future 
work investigating the developmental stage at which IRF2 
acts and whether IRF2 affects the function of these mono-
cyte subsets is warranted.
Among the studies that have identified specific immune 
cell types negatively impacted by IRF2 deficiency, some 
demonstrate a link between elevated type I IFN production 
and/or signaling and immune cell dysfunction. Knocking 
out IFN AR1 restores the normal phenotype of some af-
fected immune subsets (Hida et al., 2000; Honda et al., 2004; 
Ichikawa et al., 2004; Sato et al., 2009; Minamino et al., 2012) 
but not the developmental arrest of NK cells in the bone 
marrow (Ichikawa et al., 2004), suggesting that IRF2 facil-
itates the development and maturation of different immune 
cell types by disparate mechanisms. The involvement of type 
I IFN in immune cell development and function is further 
confounded by a recent study demonstrating that NK cells 
from mice deficient in IFN AR1 or STAT1, which signals 
downstream of the IFN-α/β receptor, are defective in expan-
sion and memory cell formation after mouse cytomegalovi-
rus infection (Madera et al., 2016). Hence, the contribution 
of IFN signaling to IRF2-dependent effects on immune cell 
development might differ before and after viral challenge. 
IRF2 also positively regulates expression of some genes (Taki, 
2002) and therefore can act in an IFN-independent way by 
transcriptionally regulating diverse host genes important for 
cell proliferation and activation. A recent study of human 
monocytes identified a single-nucleotide polymorphism con-
trolling IRF2 expression level in response to LPS and IFN-γ 
and identified a network of 300 genes differentially regulated 
by IRF2 levels (Fairfax et al., 2014).
Because NK cells, cDCs, and monocytes are most dra-
matically affected by IRF2 deficiency, we performed a series of 
depletion and reconstitution experiments to determine their 
roles in alphavirus infection and pathogenesis. Even though 
cells with natural killer activity are found in the cerebrospinal 
fluid of mice with acute SINV encephalitis (Griffin and Hess, 
1986), there are no significant differences in SINV replication 
and pathogenesis of both footpad and intracerebral infections 
in NK cell–deficient mice compared with that of NK cell–
normal mice (Hirsch, 1981). These data are consistent with 
our results of NK cell depletion by antibody treatment in WT 
mice and suggest that NK cells are dispensable for control of 
SINV infection. However, the role of phagocytic cells includ-
ing cDCs and monocytes in SINV neuroinvasion is inconclu-
sive given the difficulty of having an ideal depletion system for 
these populations (Chow et al., 2011). We have found that clo-
dronate treatment is highly variable and inefficient at equally 
depleting all the cDCs, macrophages, and monocytes. Gener-
ation of conditional knockout mice will allow direct interro-
gation of IRF2 function in the development and response of 
specific cell types to SINV infection in future studies.
Moreover, we have discovered a B cell defect in Irf2−/− 
mice. Significantly lower numbers of splenic B cells are pres-
ent in Irf2−/− mice on days 1 and 2 p.i. with SVN, suggesting 
that B cell homing or proliferation might be affected upon 
viral infection. Consistent with our finding, a previous study 
demonstrated that B220hi/surface IgM+ cells representing 
newly generated and returning mature B cells exist at lower 
numbers in the bone marrow of Irf2−/− mice (Matsuyama et 
al., 1993). Serum IgG2a levels in Irf2−/− mice are significantly 
reduced, and both their bone marrow cells and splenocytes 
are less responsive to LPS and cytokines (Matsuyama et al., 
1993). We have also found a significantly lower number of 
B cells and attenuated IgG response in Irf2−/− mouse brains 
despite similar levels of neutralizing antibodies in the serum 
of WT and Irf2−/− animals (Fig. 6). Because by days 6–7 p.i. 
none of the infected WT mice have detectable virus in their 
brains (Fig. 1 C), these findings suggest that B cells and vi-
rus-specific antibody responses might contribute to viral 
clearance and disease resolution in the CNS. In support of 
that, B cell–deficient μMT mice are significantly more sus-
ceptible to lethal neuroinvasion by SVN (Fig.  7 A), which 
demonstrates a protective role for B cells.
B cells are known to be critical for protection of 
SINV-infected mice from neuropathology, as antibodies can 
mediate viral clearance from the CNS by a mechanism that 
is distinct from classical antibody-dependent cell-mediated 
cytotoxicity or complement-dependent lysis (Levine et al., 
1991). Some of the monoclonal antibodies that recognize 
major epitopes of SINV E1 and E2 envelope glycoproteins 
are able to clear the virus from the brain and spinal cord of 
SINV-infected SCID mice (Levine et al., 1991). Because 
adoptive transfer of naive B cells and serum from infected 
WT mice fails to rescue Irf2−/− mice from lethal neuroinva-
sion (Fig. 7, B and C), IRF2 is likely required for the proper 
localization of B cells and antibodies to the CNS. A recent 
study using a mouse model of genital herpes infection has 
defined a requirement for CD4 T cells, specifically memory 
CD4 T cells, in protection of neuronal tissues after immuni-
zation at a distal site (Iijima and Iwasaki, 2016). Memory CD4 
T cells secrete IFN-γ to mediate BBB permeability and op-
timal antibody penetration into the dorsal root ganglia and 
spinal cord. IRF2 might regulate memory CD4 T cell func-
tion or recruitment to the neuronal tissue. Alternatively, IRF2 
might be involved in the proper transcriptional control of 
chemokine and chemokine receptor genes that recruit B cells 
to sites of SINV infection or promote their proliferation in the 
CNS. In response to SINV infection, expression of local in-
flammatory chemokines and cytokines that attract leukocytes 
into the CNS and facilitate B cell proliferation and differen-
tiation increase rapidly, and surface expression of chemokine 
receptors is also detected on infiltrating B cells (Metcalf et al., 
2013). The exact mechanism of how IRF2 controls B cell and 
antibody access to the CNS needs to be further investigated.
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In conclusion, we have demonstrated a novel function 
for IRF2 in protecting mice from lethal viral neuroinvasion, 
which is dependent on the normal development and mat-
uration of the immune compartment and a virus-specific 
B cell response in the CNS. The recent Zika virus and chi-
kungunya virus outbreaks of unprecedented scale in multiple 
countries urge the development of antivirals and prophylactic 
treatments to prevent global spread of emerging viruses that 
can cause severe disease in the CNS (Schuffenecker et al., 
2006; Pialoux et al., 2007; Powers and Logue, 2007). Given 
type I IFN’s clinical applications and potential effects on vac-
cine efficacy, our study is highly relevant and enhances our 
understanding of the multifaceted role of IFN regulators in 
the modulation of immune responses.
MAterIAlS And MethodS
Mice and infections
Irf2+/− mice on a pure C57BL/6J background were obtained 
from T.W. Mak (University of Toronto, Toronto, Canada; Mat-
suyama et al., 1993) and maintained and bred at the Compara-
tive Bioscience Center (CBC) of The Rockefeller University 
to generate Irf2−/− pups and WT littermate controls. B cell–
deficient μMT (B6.129S2-Ighmtm1Cgn/J) and C57BL/6J mice 
were purchased from The Jackson Laboratory and maintained 
and bred at the CBC of The Rockefeller University to gen-
erate μMT pups and age-matched WT C57BL/6J controls. 
24–26-d-old mice of both gender were infected either i.p. 
or intracranially with 13,000 PFU of the SINV strain, SVN, 
diluted in PBS. The i.p. lethal dose, 50% for SVN was pre-
viously determined to be >3 × 107 PFU by i.p. infection 
of CD-1 mice (Dubuisson et al., 1997). Mice were infected 
i.p. at 24–26 d old with 10,000 PFU of VSV, San Juan strain 
(Bick et al., 2003) diluted in PBS. For assessment of morbidity 
and mortality, mice were monitored daily using the following 
scoring system: 0, no disease signs; 1, ruffled fur; 2, mild to 
moderate hind limb weakness; 3, severe hind limb weakness/
dragging; 4, complete loss of hind limb function; 5, moribund; 
and 6, death. For tissue collection, mice were euthanized with 
CO2 and exsanguinated via cardiac puncture. Livers, spleens, 
and brains were collected, weighed, and stored at −80°C. 
All experiments in mice were performed at the CBC under 
protocols approved by the Institutional Animal Care and Use 
Committee at The Rockefeller University.
Virus assays
Virus titers were determined as previously described (Levine 
et al., 1991). Frozen tissue was homogenized in 500 µl PBS to 
generate liver, spleen, and brain homogenates that were then 
clarified by centrifugation. The amount of infectious virus 
was determined by plaque formation on BHK-21 cells. Be-
cause 70% of the Irf2−/− mice succumbed to SVN infection 
between days 6 and 8 p.i., serum samples and tissues from less 
than three mice were titered on days 6 and 7 p.i. Data were 
plotted as the mean log10 value of PFU for each animal and 
the mean of each genotype group per time point p.i. The 
limit of detection (in log10) for the plaque assay (one plaque 
detected at 1:10 dilution in one of the duplicate plaque assay 
wells) is 1.3979. For statistical purposes, samples in which no 
virus was detected at a 1:10 dilution were assigned a value of 
0.7, which is halfway between the limit of detection and zero. 
Virus titers per milliliter of serum, gram of tissue (brain and 
liver), or whole spleen were plotted. To determine SVN RNA 
levels in the brains of infected mice, 500 ng of total RNA 
extracted from the right halves of the brains was used in a 
one-step quantitative real-time PCR assay using primers and 
a TaqMan probe targeting the nsP2 region of SINV. Primer 
pairs for SINV TaqMan quantitative RT-PCR (RT-qPCR) 
were obtained from H. Chung (The Rockefeller University, 
New York, NY) and are listed in Table S1. RNA from mouse 
brains was amplified using RNA Master Hydrolysis Probes 
(Lightcycler 480; Roche) under the following thermal con-
ditions: RT at 63°C for 3 min; denaturation at 95°C for 30 s; 
45 cycles of amplification at 95°C for 15  s, 60°C for 30  s, 
and 72°C for 1 s; and a final cooling step at 40°C for 10 s. 
Viral RNA copy number of a given brain sample was then 
determined by comparing the threshold cycle (CT) value 
to a standard curve of serial 10-fold dilutions of purified in 
vitro transcribed SVN RNA.
BBB permeability
Permeability of the BBB was quantified by Evans blue 
using standard techniques (Wang et al., 2004; Rhode-
house et al., 2013). Irf2−/− mice and WT littermates were 
injected with Evans blue dye i.p. at 3% in 100  µl of ster-
ile PBS. 3  h later, mice were anesthetized with ketamine/
xylazine; blood was collected by cardiac puncture followed 
by transcardial perfusion to flush the remaining blood from 
the cerebrovasculature. Brains were rapidly harvested and 
weighed. Brains were homogenized with magnetic beads in 
0.5  ml ice-cold PBS in TissueLyser followed by centrifu-
gation at 15,000 rpm for 5 min at 4°C. Supernatants were 
used for fluorescence measurements (excitation at 540 nm 
and emission at 680 nm).
rt-qPcr
The left halves of the brains were homogenized in PBS, and 
the supernatant was stored in TRIzol at −80°C. Phase separa-
tion was performed according to the manufacturer’s instruc-
tions, followed by RNA isolation with an RNeasy mini kit 
(QIA GEN). RNA was quantified using a nanodrop spectro-
photometer. 1 µg of input RNA was used as a template for RT 
using SuperScript III (Invitrogen) and random hexamers. RT-
qPCR was performed using 5 µl of 10-fold–diluted cDNA 
in a SYBR green quantitative PCR assay on a real-time PCR 
system (LightCycler 480; Roche). Primer pairs for RT-qPCR 
are listed in Table S1. Primers for measuring IFI TM3 and 
BST2 mRNAs were obtained from M. Dittmann (New York 
University School of Medicine, New York, NY). Expression 
levels of mouse ISGs were determined by normalizing the 
target transcript CT value to the CT value of the endogenous 
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housekeeping RPS11 transcript. This normalized value was 
used to calculate the fold-change relative to the mean of the 
baseline WT controls (CT method).
cytokine and chemokine protein quantification 
by cytometric bead array
IL-6 and MCP-1 levels in serum and clarified brain homog-
enates were determined using a cytometric bead array mouse 
inflammation kit (BD). The right halves of the brains were ho-
mogenized in radioimmunoprecipitation assay buffer + prote-
ase inhibitor, and the supernatant was stored at −80°C. Serum 
and clarified brain homogenates diluted 1:5 were used as input 
samples, and the manufacturer’s protocol was followed. The 
limit of detection was 20 pg/ml of serum or brain homogenate.
elI SA
ELI SA was performed to measure SINV-specific antibody 
(Kulcsar et al., 2015). 96-well Maxisorp plates (Thermo Fisher 
Scientific) were coated with 106 PFU/well of polyethylene 
glycol–precipitated SINV strain SVN in 0.1 M Na2CO3, pH 
9.6, at 4°C overnight. Blocking buffer (10% FBS and 0.05% 
Tween 20 in PBS) was added for 2 h at 37°C. The right halves 
of the brains were homogenized in radioimmunoprecipita-
tion assay buffer + protease inhibitor, and the supernatant 
was stored at −80°C. Serum samples diluted 1:10 and brain 
homogenates diluted 1:2 in blocking buffer were added to 
the coated plates and incubated at 4°C overnight. Bound 
antibodies were detected using HRP-conjugated goat anti–
mouse IgG (Jackson ImmunoResearch Laboratories, Inc.) or 
IgM (Sigma-Aldrich) diluted 1:1,000 in blocking buffer and 
incubated at room temperature for 2 h. Plates were developed 
using the TMB Liquid Substrate System (Sigma-Aldrich) for 
ELI SA with H2SO4 as a stop solution. Absorbance was read at 
450 nm in a FLUOstar Omega Plate Reader (BMG Labtech). 
Mean OD values for serum and brain samples from unin-
fected WT and Irf2−/− mice were subtracted from the OD 
values of samples from the infected mice.
Measurement of IFn levels
The Verikine Mouse IFN-α ELI SA kit (PBL Interferon 
Source) was used to measure IFN-α levels by following the 
manufacturer’s instructions. The range of detection was 12.5–
400 pg IFN-α per ml serum.
Splenocyte isolation
Single-cell suspensions from spleen tissues were prepared as 
previously described (Schreiber et al., 2013). In brief, whole 
mouse spleens were mechanically disrupted and incubated 
with HBSS + 5% FBS + 0.5 mg/ml collagenase (Roche) at 
37°C for 30 min. Cells were filtered through 100-µM cell 
strainers and washed. Red blood cells were removed by in-
cubating the pellet with 1 ml ACK lysing buffer (Gibco) at 
room temperature for 5 min. Splenocytes were then pelleted 
and resuspended in HBSS + 5% FBS, and live cells were 
counted using trypan blue exclusion.
Flow cytometry
Approximately 3 × 106 cells were used for immunophe-
notyping by flow cytometry. Cells were blocked using rat 
anti–mouse CD16/CD32 (eBioscience) and stained with 
antibodies for 30 min at 4°C. Cells were then fixed and 
resuspended in 150 µl for flow cytometric acquisition. For-
ward- and side-scatter parameters were used to gate out 
doublets. The antibodies used were from BD, Thermo Fisher 
Scientific, eBioscience, or BioLegend: CD3 (145-2C11), 
CD4 (RM4-5), CD8 (53-6.7), B220 (RA3-6B2), CD11b 
(M1/70), CD11c (N418), MHC II (I-A/I-E; M5/114.15.2), 
Ly6G (1A8), Ly6C (HK1.4), CD115 (AFS98), F4/80 (BM8), 
NK1.1 (PK136), and CD27 (LG.3A10). Cell types were de-
fined as follows: T cells (CD3+), CD4 T cells (CD3+ CD4+), 
CD8 T cells (CD3+ CD8+), B cells (CD3− B220+), DCs 
(CD3− B220− Ly6G− CD115− MHC II+ CD11c+), CD8+ 
cDCs (CD3− B220− Ly6G− CD115− MHC II+ CD11c+ 
CD8+), CD11b+ cDCs (CD3− B220− Ly6G− CD115− 
MHC II+ CD11c+ CD11b+), macrophages (CD3− B220− 
Ly6G− CD115− CD11c− CD11b− F4/80+), and NK cells 
(CD3− B220− Ly6G− CD115− CD11c− F4/80− NK1.1+ 
CD11bhi/lo CD27hi/lo). In addition, monocytes were gated as 
previously described (CD3− B220− Ly6G− NK1.1− CD115+ 
CD11b+; Hanna et al., 2011). CD115+ and CD11b+ cells 
were then grouped based on their expression of Ly6C 
(Ly6Chi and Ly6Clo monocytes). Fluorescence minus one 
controls were used to define populations positively stained 
with anti-Ly6G, -Ly6C, -CD115, and -NK1.1 antibodies. 
Data were acquired using a flow cytometer (LSR II; BD) 
and FACS Diva software (version 8.0) and analyzed using 
FlowJo (8.8.7; Tree Star). The flow cytometric gating strat-
egy can be found in Fig. S1.
histology and immunohistochemistry
After euthanasia with CO2, tissues (brain, liver, kidney, spleen, 
pancreas, heart, lungs, spinal cord, and bone marrow) from 
uninfected Irf2−/− and WT mice and moribund SVN- 
infected Irf2−/− and age-matched WT mice 6–7 d after infec-
tion were collected and fixed by immersion in 10% neutral 
buffered formalin for 48 h, processed in ethanol and xylene, 
embedded in paraffin, sectioned at 5-µm thickness, stained 
with H&E, and examined by a board-certified veterinary pa-
thologist (S. Monette). To identify the small percentage of in-
fected WT mice with positive brain viral titers, the left halves 
of the brains were harvested on day 5 p.i. and fixed in neutral 
buffered formalin, whereas the right halves were homoge-
nized, and supernatant was collected for RNA extraction 
to determine SVN RNA copy number by SINV TaqMan 
RT-qPCR. Then, the brain samples with positive viral RNA 
levels were processed and embedded in paraffin for histolog-
ical examination. For histological analysis of inflammation, 
sections were stained with H&E and antibodies for specific 
immune cell markers and were scored in a blinded fashion 
using a scale of zero to four as follows: 1, minimal; 2, mild; 
3, moderate; and 4, severe.
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Tissues were stained by immunohistochemistry for 
CD3 (primary antibody VP-RM01 [Vector Laboratories] ap-
plied at a concentration of 1:100 after heat-induced epitope 
retrieval [HIER] in a buffer, pH 9.0), B220 (550286; BD; 
1:200, HIER, pH 6.0), Mac-2 (CL8942B; Cedarlane; 1:100; 
HIER, pH 6.0), granzyme B (ab4059; Abcam; 1:250; HIER, 
pH 6.0), cleaved caspase-3 (9661; Cell Signaling Technology; 
1:250; HIER, pH 6.0), and SINV capsid (rabbit polyclonal; 
Rice and Strauss, 1982; 1:10,000, HIER, pH 6.0). Mac-2 
and SINV capsid staining was performed manually with an 
avidin-biotin detection system (Vectastain ABC Elite kit; 
PK-6100; Vector Laboratories). Other stains were performed 
on an automated stainer (Bond RX; Leica Biosystems) using 
the Bond Polymer Refine detection kit (DS9800; Leica Bio-
systems). With both manual and automated methods, the pos-
itive signal was labeled with 3,3′-Diaminobenzidine (DAB), 
and sections were counterstained with hematoxylin. Sections 
were also stained by the TUN EL method as previously de-
scribed (Gavrieli et al., 1992). All H&E, immunohistochem-
istry, and TUN EL slides were examined by a board-certified 
veterinary pathologist (S. Monette).
Images were acquired using a microscope (BX45; 
Olympus) using a 20× objective, a DP25 camera, and cellSens 
Entry software (1.9; Olympus). For each stain in each ani-
mal, eight images measuring each 567,162 µm2 were acquired 
from defined regions of interest as shown in Fig. S2. Images 
were then analyzed using ImageJ software (1.49; National In-
stitutes of Health) with the Color Deconvolution plugin (1.5; 
Ruifrok and Johnston, 2001) to determine the staining area. 
After deconvolution with the H DAB vector, the Threshold 
tool (lower and upper values set at 0 and 150 [B220 stain] or 
170 [SINV capsid stain], respectively) was applied to the DAB 
component to produce a black and white image. The Mea-
sure tool was used to determine the percentage of positive 
(black) pixels (positive staining area). The number of positive 
cells was also counted manually from the same images.
In vivo blocking antibody treatment 
and immune cell depletion
WT and Irf2−/− mice were treated i.p. with anti-IFN AR1 an-
tibody (clone MAR1-5A3; Sheehan et al., 2006) before SVN 
infection on day −1 (500 µg or 1 mg) or on day 2 p.i. (500 
µg) or with mouse IgG1 isotype control (clone MOPC21; 
Bio X Cell) on day −1 before virus infection. In some exper-
iments, WT mice were depleted of NK cells with anti-NK1.1 
antibody (clone PK136; Bio X Cell) or treated with mouse 
IgG2a isotype control (clone C1.18.4.; Bio X Cell) 1 d before 
infection (300 µg). For MNP depletion, WT and Irf2−/− mice 
were treated i.p. with 200 µl clodronate or PBS liposome on 
day −3 before SVN infection.
Adoptive transfer of B cell and serum
For B cell adoptive transfer, whole spleens from WT mice 
were harvested, and single-cell suspensions of splenocytes 
were obtained, from which B cells (CD19+) were isolated by 
negative selection using magnetic particles bound to a cock-
tail of antibodies recognizing non–B cells according to the 
manufacturer's protocol (STE MCE LL Technologies). CD19+ 
enriched cells from each of the WT mice were counted, and 
2 × 106 cells from each animal were pooled together for i.p. 
injection into naive WT and Irf2−/− mice 1 d before SVN 
infection (2 × 106 cells per injection). For serum transfer, 
WT mice were infected with SVN, and serum was harvested 
on day 7 p.i. Samples were heat inactivated at 56°C for 30 
min and pooled together for later injection. Naive WT and 
Irf2−/− mice were infected with SVN and 1 d later treated 
i.p. with 200 µl of serum.
Plaque reduction neutralization test (Prnt)
Serum samples from uninfected mice diluted 1:100 were 
incubated with different concentrations of SVN. After in-
cubation at 37°C for 1  h, 200  µl of the mixture (200  µl 
serum dilution + 200 µl virus dilution) was inoculated onto 
a monolayer of BHK-21 cells in 6-well plates using a final 
2.25% avicel overlay, and 30 h p.i., the cells were visualized 
with crystal violet staining. The concentration of virus that 
gave ∼200 plaques per well was chosen for the subsequent 
PRNT. Serum samples from day 5 SVN-infected WT and 
Irf2−/− mice initially diluted 1:100 were then serially diluted 
threefold and mixed with a constant concentration of virus.
Statistical analyses
Survival was compared using Kaplan-Meier survival curves 
(log-rank test). Differences between groups during the course 
of infection were determined using two-way ANO VA and 
Bonferroni posttests. Differences between groups at a single 
time point were determined using an unpaired, two-tailed 
Student’s t test with a 95% confidence interval. All statistical 
analyses were done using Prism 5 (GraphPad Software).
online supplemental material
Fig. S1 shows the FACS gating strategy for defining T cell, 
B cell, DC, macrophage, NK cell, and monocyte populations 
in the mouse spleen. Fig. S2 shows the eight different locations 
in the brain from which images of SVN-infected WT and 
Irf2−/− mice were taken for quantification of B cell staining. 
Table S1 shows the sequences of primers used for ISG and 
SINV TaqMan RT-qPCR.
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